A citation-based method for searching scientific literature

B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
Times Cited: 543



Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
Times Cited: 1429




List of shared articles



Times cited

The role of genomics in global cancer prevention.
Ophira Ginsburg, Patricia Ashton-Prolla, Anna Cantor, Daniela Mariosa, Paul Brennan. Nat Rev Clin Oncol 2021
3

BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.
Ewelina Szczerba, Katarzyna Kamińska, Tomasz Mierzwa, Marcin Misiek, Janusz Kowalewski, Marzena Anna Lewandowska. Genes (Basel) 2021
0

Clinical Effects of Early or Surgical Menopause.
Sheryl A Kingsberg, Lisa C Larkin, James H Liu. Obstet Gynecol 2020
11

Population-based genetic testing for Women's cancer prevention.
Olivia Evans, Faiza Gaba, Ranjit Manchanda. Best Pract Res Clin Obstet Gynaecol 2020
5

Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
Andreia Brandão, Paula Paulo, Manuel R Teixeira. Int J Mol Sci 2020
5

A Reference System for BRCA Mutation Detection Based on Next-Generation Sequencing in the Chinese Population.
Shoufang Qu, Qiong Chen, Yuting Yi, Kang Shao, Wenxin Zhang, Yin Wang, Jian Bai, Xuchao Li, Zhiyuan Liu, Xiaowen Wang,[...]. J Mol Diagn 2019
3

Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.
Veronica Fragoso-Ontiveros, Jose Antonio Velázquez-Aragón, Paulina Maria Nuñez-Martínez, Maria de la Luz Mejía-Aguayo, Silvia Vidal-Millán, Abraham Pedroza-Torres, Yuliana Sánchez-Contreras, Miguel Angel Ramírez-Otero, Rodolfo Muñiz-Mendoza, Julieta Domínguez-Ortíz,[...]. PLoS One 2019
3

Multi-gene Panel Testing in Breast Cancer Management.
Christos Fountzilas, Virginia G Kaklamani. Cancer Treat Res 2018
7

Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.
E Dagan, R Gershoni-Baruch, A Kurolap, G Fried. Eur J Cancer Care (Engl) 2017
4

Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.
Chana Wiesman, Esther Rose, Allison Grant, Adam Zimilover, Susan Klugman, Nicole Schreiber-Agus. Genet Med 2017
10

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Sari Lieberman, Amnon Lahad, Ariela Tomer, Carmit Cohen, Ephrat Levy-Lahad, Aviad Raz. Genet Med 2017
18



Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
S Lheureux, K Karakasis, P Harter, C Scott, M Bacon, J Bryce, N Le Fur, E Pujade-Lauraine, A M Oza. Gynecol Oncol 2016
8

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
61

Genetic screening for gynecological cancer: where are we heading?
Ranjit Manchanda, Ian Jacobs. Future Oncol 2016
7

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
Katherine Karakasis, Julia V Burnier, Valerie Bowering, Amit M Oza, Stephanie Lheureux. Front Oncol 2016
12


Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.
Zora Baretta, Simone Mocellin, Elena Goldin, Olufunmilayo I Olopade, Dezheng Huo. Medicine (Baltimore) 2016
62

The future of clinical cancer genomics.
Kenneth Offit. Semin Oncol 2016
13